至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Rational re-design of Lactobacillus reuteri 121 inulosucrase for product chain length control

 RSC Adv. 2019; 
Thanapon Charoenwongpaiboona, Methus Klaewklaab, Surasak Chunsrivirotab, Karan Wangpaiboona, Rath Pichyangkuraa, Robert A. Fieldc and Manchumas Hengsakul Prousoontorn
Products/Services Used Details Operation
Gene Synthesis The construct InuΔ699His17 synthesised by Genscript, was used as a parental gene (wild-type) in this study. Site-directed mutagenesis was performed by the PCR overlapping extension method27 using PrimeStar™ DNA polymerase (Takara). The primers used for mutagenesis are described in the ESI section (Table S1†). The variant genes were ligated into pET-21b (Novagen™) at Xhol and NdeI sites and were further transformed into E. coli strain Top10 (Invitrogen™) for cloning purposes. Get A Quote

摘要

Fructooligosaccharides (FOSs) are well-known prebiotics that are widely used in the food, beverage and pharmaceutical industries. Inulosucrase (E.C. 2.4.1.9) can potentially be used to synthesise FOSs from sucrose. In this study, inulosucrase from Lactobacillus reuteri 121 was engineered by site-directed mutagenesis to change the FOS chain length. Three variants (R483F, R483Y and R483W) were designed, and their binding free energies with 1,1,1-kestopentaose (GF4) were calculated with the Rosetta software. R483F and R483Y were predicted to bind with GF4 better than the wild type, suggesting that these engineered enzymes should be able to effectively extend GF4 by one residue and produce a greater quantity of G... More

关键词